Emerging Technologies
Clinician innovators across the region see the next phase of healthcare AI focusing on trust and responsible adoption after a year of rapid experimentation.
Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.
Ceribell received breakthrough device designation for its LVO stroke detection monitor, and Naox Technologies secured 510(k) clearance for its in-ear EEG device.
VeriFact analyzes statements in AI-generated clinical text against patients’ EHRs to identify factual errors, achieving 93.2% agreement with clinicians.
The company will use the funds to accelerate commercialization of its brain-signal AI technology and expand its cognitive health applications.
Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.
The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring device.
Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.
Screening rates in northern Queensland lag behind the statewide average.
The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.